Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.
about
Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactionsHepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implicationProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityNanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.Meta-analysis: superior treatment response in Asian patients with hepatitis C virus genotype 6 versus genotype 1 with pegylated interferon and ribavirinEfficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysisPrevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.Role of genetic polymorphisms in hepatitis C virus chronic infection.Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysisPharmGKB summary: peginterferon-α pathway.Role of IL28B for chronic hepatitis C treatment toward personalized medicine.Review article: genetic factors that modify the outcome of viral hepatitis.Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.Targeting IFN-λ: therapeutic implications.Pharmacogenetics of ribavirin-induced anemia in HCV patients.Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks.IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.
P2860
Q27014831-BFA8DDC1-CA29-47F6-90B5-618A2590FEECQ27024231-BB3796AA-98E3-42F0-B9E4-D6FE53A4B343Q28083100-E9E14474-CC5C-4652-B37A-B3889D622E4AQ33559298-691D6805-63F7-4AA7-95B7-CF8CED17E4B8Q35153869-A700DF6F-E213-4EC1-8955-E7B6329031CAQ35194590-F8E9CFAF-0BBF-47A6-9043-AA3332DFA195Q35566443-1918A448-0FB9-4BAD-ADA6-4705F4D4BB10Q35779058-317A83D2-6B40-4EDE-BD61-231734395ED5Q35799774-C5A11DC4-0E2E-4530-9340-01AECB7994B6Q36590755-D23C0BFA-F3DC-43FA-AE86-36C544FFAC2BQ38170161-DFF68BCE-8AFA-4670-81CF-FA6AB993EF7CQ38198089-3590F756-8AAE-4EED-96FC-6092A6FA5EE2Q38445623-33D28A22-6E4C-403D-B22D-EE8EC79CC5BFQ38816811-C4C1B3D7-DDC2-43E5-B5C1-F963A5094BD3Q40650428-B37B3677-BF26-4B87-99D0-3A5FB0B33DCCQ41556755-FE9DDE9C-1682-4838-BD57-DA10C87C5513Q42221315-D586D3A9-8FC3-4B2F-A7E6-2E791C822124
P2860
Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Role of IL28B and inosine trip ...... C virus genotype 6 infection.
@ast
Role of IL28B and inosine trip ...... C virus genotype 6 infection.
@en
type
label
Role of IL28B and inosine trip ...... C virus genotype 6 infection.
@ast
Role of IL28B and inosine trip ...... C virus genotype 6 infection.
@en
prefLabel
Role of IL28B and inosine trip ...... C virus genotype 6 infection.
@ast
Role of IL28B and inosine trip ...... C virus genotype 6 infection.
@en
P2093
P2860
P356
P1476
Role of IL28B and inosine trip ...... C virus genotype 6 infection.
@en
P2093
D K-H Wong
J M-C Chan
O T-Y Tsang
P2860
P304
P356
10.1111/JVH.12047
P577
2013-04-12T00:00:00Z